Area of research
Epidemiology · Physiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Adipose Tissue and Metabolism, Diabetes, Cardiovascular Risks, and Lipoproteins, and Adipokines, Inflammation, and Metabolic Diseases.
Adipose single cell epigenome and transcriptome localize genetic risk for cardiometabolic disease and accelerated aging.
Metabolic Dysfunction-associated Steatotic Liver Disease Alters Fatty Acid Profiles in the Liver and Adipose Tissue.
Unraveling the Factors Associated With Digital Health Intervention Uptake: Cross-Sectional Study.
Increased secretion of adipocyte-derived extracellular vesicles is associated with adipose tissue inflammation and the mobilization of excess lipid in human obesity
Increased secretion of adipocyte-derived extracellular vesicles is associated with adipose tissue inflammation and the mobilization of excess lipid in human obesity.
m6A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1
Single nucleus RNA-sequencing integrated into risk variant colocalization discovers 17 cell-type-specific abdominal obesity genes for metabolic dysfunction-associated steatotic liver disease
Single nucleus RNA-sequencing integrated into risk variant colocalization discovers 17 cell-type-specific abdominal obesity genes for metabolic dysfunction-associated steatotic liver disease
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Integration of single cell omics with biobank data discovers
<i>trans</i>
effects of
<i>SREBF1</i>
abdominal obesity risk variants on adipocyte expression of more than 100 genes
Modification in mitochondrial function is associated with the FADS1 variant and its interaction with alpha-linolenic acid-enriched diet-An exploratory study.
Protein Phosphatase 1 Regulatory Subunit 3 Beta rs4240624 Genotype Is Associated With Gallstones and With Significant Changes in Bile Lipidome
Unraveling the Factors Associated With Digital Health Intervention Uptake: Cross-Sectional Study (Preprint)
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease
Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk - A stop diabetes pragmatic randomised trial.
Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.
Immigrants' perspectives on healthy life and healthy lifestyle counseling: a focus group study.
Sex Differences in the Indole-3-propionic Acid Responses to Laparoscopic Roux-en-Y gastric Bypass
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease.
Rare ATG7 genetic variants predispose patients to severe fatty liver disease
Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease.
Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease.
Integration of questionnaire-based risk factors improves polygenic risk scores for human coronary heart disease and type 2 diabetes.
PSD3 downregulation confers protection against fatty liver disease.
Digitally Supported Lifestyle Intervention to Prevent Type 2 Diabetes Through Healthy Habits: Secondary Analysis of Long-Term User Engagement Trajectories in a Randomized Controlled Trial.